New Scientific Evidence Available:
How Echinacea Stimulates the Antiviral Immune Defense.
Webinar
Webinar ended
About This Webinar
The Covid-19 epidemic has ultimately demonstrated the value of a strong immune defense. With this respect, SARS-CoV-2 shares similarities with other known respiratory pathogens.

How Echinacea purpurea affects our immune responses to prevent viral infections and inhibits respiratory agents, including Coronaviruses, has now been explored in preclinical studies using state-of-the-art medical genetic analysis. Recent studies have evaluated how actions peak in the effective prevention of respiratory tract infections in children. Thereby, a novel approach was studied that could help to solve the yet unresolved issue with antibiotic overuse.

The conference aims to give a thorough overview and to discuss the medicinal value of Echinacea in particular as an option to support immune defense in combating viral respiratory tract infections and associated health issues.
Agenda
  • Effects of Echinacea purpurea on the Antiviral Immune Defense - Prof. Wim Vanden Berghe
  • Echinacea purpurea a Source for Antiviral Activity - Dr. Ross Walton
  • Prevention of RTIs and Reduction of Antibiotic Use in Children - Dr. med. Mercedes Ogal
Presenters
1628674332-33b94a309760e1b2
Dr. med. Rainer Stange (Chair)
Senior Researcher at the Charité – Universitätsmedizin Berlin, Germany

M.D., PhD, Internal Medicine, Natural Medicine, Physical Therapy (approval by Doctors’ Chamber). Presently Senior Researcher at Charité – Universitätsmedizin Berlin. Long-term clinical experience in Natural Medicine. Vice-president of German Society for Phytotherapy (GPT), president of German Medical Association for Natural Medicine (ZAEN).

Co-editor of Lehrbuch der Naturheilverfahren (Textbook of Natural Medicine, Thieme,
Germany, 2010). Appr. 45scientific publications in PubMed.
1625149733-3a07f844fb36c734
Dr. med. Mercedes Ogal
Pediatric Specialist, Paediatric Clinic, Brunnen, Switzerland

Mercedes Ogal has worked as a specialized integrative paediatrician for 14 years in a pediatric medical practice in Central Switzerland. She developed her deep knowledge in complementary medicine since 1991 in phytotherapy, acupuncture, homoepathy, medical hypnosis and orthomolecular medicine and owns certificates in various medicinal disciplines. Furthermore, Dr. Mercedes Ogal is author of publications and speaker on various national and international lectures and conferences.
1628674435-8045bd8c1baa8cd7
Prof. Wim Vanden Berghe
Epigenetic Signaling Lab, PPES, University Antwerp, Belgium

Prof. Wim Vanden Berghe obtained his PhD in Biochemistry-Biotechnology at the University of Ghent in 1999. After postdoctoral research at the University of Montpellier, Stellenbosch and Oxford, he was appointed professor of Epigenetics in 2009 at the lab for Protein chemistry, proteomics and epigenetic signaling (PPES, Universities of Antwerp and Gent, Belgium). With his current research, he is characterizing epigenetic regulation of kinase signaling pathways to modulate inflammatory disease phenotypes
with phytomedicinal or pharmacological compounds in cancer, atherosclerosis, obesity, infectious disease or neurodegeneration.
1625149402-4f274862eb14c0a4
Dr. Ross Walton
Therapeutic Frontier, Imperial College London, United Kingdom

Ross Walton attained his PhD from Imperial College investigating mechanism of
respiratory viral induced modification of allergic airway responses. He has substantial experience with complex in vivo and human models of virus infection, including rhino-
virus, respiratory syncytial virus and influenza. Employing state-of-the-art analytical approaches in patient samples alongside complimentary in vivo models, he explores
the cellular interactions underpinning the immunological basis of chronic respiratory
diseases and viral infection.
Powered by BigMarker